|
|
Volumn 32, Issue 6, 1997, Pages 460-480
|
|
Fosinopril: Clinical pharmacokinetics and clinical potential
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALACEPRIL;
ALLOPURINOL;
ANTIDIABETIC AGENT;
ANTIHYPERTENSIVE AGENT;
BENAZEPRIL;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CALCIUM CHANNEL BLOCKING AGENT;
CAPTOPRIL;
CILAZAPRIL;
DELAPRIL;
DIGOXIN;
DIPEPTIDYL CARBOXYPEPTIDASE;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DIURETIC AGENT;
ENALAPRIL;
FOSINOPRIL;
FOSINOPRILAT;
GLUCOSE;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
LIPID;
LISINOPRIL;
NONSTEROID ANTIINFLAMMATORY AGENT;
PROBENECID;
RAMIPRIL;
SPIRAPRILAT;
TEMOCAPRILAT;
THIAZIDE DIURETIC AGENT;
UNINDEXED DRUG;
VASODILATOR AGENT;
ZOFENOPRILAT;
ADVERSE DRUG REACTION;
ANTIHYPERTENSIVE ACTIVITY;
BLOOD PRESSURE;
BRAIN BLOOD FLOW;
CLINICAL TRIAL;
CONGESTIVE HEART FAILURE;
COUGHING;
DRUG ABSORPTION;
DRUG ACCUMULATION;
DRUG ANALYSIS;
DRUG BILE LEVEL;
DRUG DETERMINATION;
DRUG EXCRETION;
DRUG HYDROLYSIS;
DRUG MECHANISM;
DRUG POTENTIATION;
DRUG URINE LEVEL;
GASTROINTESTINAL SYMPTOM;
GLUCOSE METABOLISM;
HEADACHE;
HEART LEFT VENTRICLE HYPERTROPHY;
HEART MUSCLE ISCHEMIA;
HEMODIALYSIS;
HUMAN;
HYPERTENSION;
INTRAVENOUS DRUG ADMINISTRATION;
KIDNEY BLOOD FLOW;
KIDNEY DISEASE;
KIDNEY FUNCTION;
LIPID METABOLISM;
LIVER DYSFUNCTION;
ORAL DRUG ADMINISTRATION;
PHARMACODYNAMICS;
PRIORITY JOURNAL;
REVIEW;
VERTIGO;
|
|
EID: 0030943533
PISSN: 03125963
EISSN: None
Source Type: Journal
DOI: 10.2165/00003088-199732060-00003 Document Type: Review |
|
Times cited : (38)
|
|
References (95)
|
